The synthetic biology—a branch of biotechnology—focusses on opportunities in the healthcare sector, involving drug delivery, protein therapeutics, biofuels, and food and agricultural product development. It provides opportunities for biotechnology entrepreneurs by enabling low-cost production. ThermoFisher Scientific capitalizes on flourishing business segments by targeting, innovating, and undertaking mergers and acquisitions.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC synthetic biology market. The APAC synthetic biology market is expected to grow at a notable CAGR during the forecast period.
APAC Synthetic Biology Market Segmentation
The APAC synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to continue to grow at the fastest rate during the forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020, while the genome engineering segment is expected to be fastest growing during the forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to garner the highest CAGR during the forecast period. The APAC synthetic biology market is segmented into China, Japan, India, South Korea, Australia, and Rest of APAC.
Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the APAC synthetic biology market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,970.70 Million |
| Market Size by 2028 | US$ 7,343.06 Million |
| CAGR (2021 - 2028) | 20.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Products
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Synthetic Biology Market is valued at US$ 1,970.70 Million in 2021, it is projected to reach US$ 7,343.06 Million by 2028.
As per our report Asia Pacific Synthetic Biology Market, the market size is valued at US$ 1,970.70 Million in 2021, projecting it to reach US$ 7,343.06 Million by 2028. This translates to a CAGR of approximately 20.7% during the forecast period.
The Asia Pacific Synthetic Biology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Synthetic Biology Market report:
The Asia Pacific Synthetic Biology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Synthetic Biology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Synthetic Biology Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Synthetic Biology Market
